Skip to content

Cesarean Scar Defect (CSD); Prevalence, Risk Factors And Possible Associated Symptoms

Cesarean Scar Defect (CSD); Prevalence, Risk Factors And Possible Associated Symptoms: A Cohort Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04605328
Acronym
isthmocele
Enrollment
225
Registered
2020-10-28
Start date
2020-12-01
Completion date
2021-12-30
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications

Keywords

niche

Brief summary

The study aims to detect the incidence of Cesarean Scar Defect (CSD) in women undergoing CS in Women Health Hospital (WHH), assiut University, to identify risk factors for development of CSD and identify the possible gynaecological symptoms related to CSD.

Detailed description

All eligible women, who will undergo CS in Women Health Hospital (WHH) will be seen on regular visits to detect the presence of CSD by ultrasound and identify its characters and a questionnaire will be fulfilled by the candidates about the gynecological symptoms related to CSD and appeared after CS.

Interventions

OTHERTwo dimension and three dimension ultrasound

Patient will undergo 2D and 3D ultrasound evaluation after CS for detection of CSD

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* All women who will undergo transverse lower segment cesarean section after 28 weeks gestational age (electively and Emergency), after counseling and written consent

Exclusion criteria

1. Rupture uterus (unscarred or scarred). 2. Upper segment CS. 3. Vertical lower segment CS.

Design outcomes

Primary

MeasureTime frameDescription
the incidence of CSD in Women health Hospital1 yearthe incidence of CSD in Women health Hospital

Contacts

Primary ContactMohamed Bahaa El-Dine, Master
midobahaa39@yahoo.com++201022422960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026